Evidence map›Paper›PMID 23811016›Full record

ArticleExperimental neurology2013

Stromal derived growth factor-1 (CXCL12) modulates synaptic transmission to immature neurons during post-ischemic cerebral repair.

Agnieszka A Ardelt, Bula J Bhattacharyya, Abdelhak Belmadani, Dongun Ren, Richard J Miller

Abstract read
In one paragraph

Article in Experimental neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Article
  3. Optogenetic and Endogenous Modulation of CaInternational journal of molecular sciences · 2025
    Review
  4. CXCL12 Engages Cortical Inhibitory Neurons to Enhance Dendritic Spine Plasticity and Structured Network Activity.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  5. Article
  6. Review
  7. Stem cell homing in periodontal tissue regeneration.Frontiers in bioengineering and biotechnology · 2022
    Review
  8. Article
  9. Article
  10. A Rare Mutation of βNeuron · 2019
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Adult neurogenesis andNeural regeneration research · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Agnieszka A ArdeltDepartment of Neurology, University of Chicago, Chicago, IL, USA; Department of Surgery (Neurosurgery), University of Chicago, Chicago, IL, USA. Electronic address: aardelt@neurology.bsd.uchicago.edu.
Bula J Bhattacharyya
Abdelhak Belmadani
Dongun Ren
Richard J Miller

Funding

CHEMOKINE RECEPTOR FUNCTION IN THE NERVOUS SYSTEMR01DA013141 · NIDA · UNIVERSITY OF CHICAGO · PI MILLER, RICHARD J · 2000 to 2015
$6.0M
NIDA NIH HHS R01 DA013141NIDA NIH HHS R01DA013141
6 · The paper itself

Abstract

In response to ischemic injury, the brain mounts a repair process involving the development of new neurons, oligodendrocytes, and astrocytes. However, the manner in which new neurons integrate into existing brain circuitry is not well understood. Here we observed that during the four weeks after transient middle cerebral artery occlusion (MCAO), doublecortin (DCX)-expressing neural progenitors originating in the subventricular zone (SVZ) were present in the ischemic lesion borderzone, where they received γ-aminobutyric acid (GABA) inputs, a feature that is common to newly developing neurons. The chemokine stromal derived factor-1 (SDF-1 or CXCL12) was enriched in lesional endothelial and microglial cells for up to four weeks after transient MCAO, and application of SDF-1 to acute brain slices enhanced GABAergic inputs to the new neurons. These observations suggest that SDF-1 is in a position to coordinate neovascularization and neurogenesis during the repair process after cerebral ischemia-reperfusion.

Indexed as

AnimalsBrain IschemiaCell ProliferationCerebral CortexChemokine CXCL12Doublecortin Domain ProteinsDoublecortin ProteinEndothelial CellsMiceMice, TransgenicMicrogliaMicrotubule-Associated ProteinsNeovascularization, PhysiologicNeural Stem CellsNeurogenesisNeuronsChemokine CXCL12Dcx protein, mouseDoublecortin Domain ProteinsDoublecortin ProteinMicrotubule-Associated ProteinsNeuropeptidesACSFAnimal modelsartificial CSFBICbicuculline methiodideBrain ischemiaCCAChemokinescommon carotid arteryCXC chemokine receptor 4CXCR4DCXdentate gyrusDGdoublecortinECAEGFPElectrophysiologyenhanced green fluorescent proteinexternal carotid arteryGABAGFAPglial fibrillary acidic proteinICAinternal carotid arteryMCAMCAOmiddle cerebral arterymiddle cerebral artery occlusionmonomeric red fluorescent proteinmRFPNeuroregenerationparaformaldehydePBSPFAphosphate buffered salineSDF-1SGZstromal derived factor-1 (CXCL12)subgranular zonesubventricular zoneSVZtetrodotoxinTTXvon Willebrand factorvWFγ-aminobutyric acid

Identifiers

PMID23811016
PMCPMC3773266

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.